Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Consolidated Statements of Operations and Comprehensive Loss
Revenue	$ 6,016	$ 5,953
Operating Expenses
Direct costs	2,696	4,290
Research and development	19,022	18,873
Selling, general and administrative	8,327	8,571
Total operating expenses	30,045	31,734
Operating Loss	(24,029)	(25,781)
Nonoperating Income and Expense
Interest income	3,599	5,117
Change in fair value of warrant liabilities	5,879	(501)
Interest expense	(8)	(42)
Other income (expense)	(522)
Total nonoperating income and expense	8,948	4,574
Pretax Loss	(15,081)	(21,207)
Share of net loss of equity method investee	70
Net Loss Attributable to Common Stockholders	(15,151)	(21,207)
Other Comprehensive Income (Loss)	173	(579)
Comprehensive Loss Attributable to Common Stockholders	$ (14,978)	$ (21,786)
Basic loss per share	$ (0.08)	$ (0.12)
Diluted loss per share	$ (0.08)	$ (0.12)
Weighted average shares outstanding - Basic	181,404,557	180,784,020
Weighted average shares outstanding - Diluted	181,404,557	180,784,020